Onderneming Exact Sciences Corporation
Aandelen
EXAS
US30063P1057
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
55,56 USD | +3,82% | -12,36% | -24,95% |
Vakgebied
Aantal werknemers: 6 550
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Screening
74,6
%
| 1 425 | 68,4 % | 1 865 | 74,6 % | +30,88% |
Precision Oncology
25,2
%
| 601 | 28,9 % | 629 | 25,2 % | +4,59% |
COVID-19 Testing
0,2
%
| 58 | 2,8 % | 6 | 0,2 % | -89,75% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
93,9
%
| 1 967 | 94,4 % | 2 346 | 93,9 % | +19,32% |
Non-United States
6,1
%
| 118 | 5,6 % | 153 | 6,1 % | +30,18% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 18-03-09 |
Paul Limburg
CTO | Chief Tech/Sci/R&D Officer | - | 06-03-18 |
Jorge Garces
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-02-21 |
Chief Tech/Sci/R&D Officer | - | 01-01-19 | |
Tomasz Beer
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-22 |
D. Coward
BRD | Director/Board Member | 59 | 01-01-15 |
Kristen Weiler
SAM | Sales & Marketing | - | 01-01-18 |
Ana Hooker
PRN | Corporate Officer/Principal | 58 | 01-01-13 |
Kyle Stacey
AUD | Comptroller/Controller/Auditor | - | 01-01-09 |
James Herriott
LAW | General Counsel | 44 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
D. Coward
BRD | Director/Board Member | 59 | 01-01-15 |
Kevin Conroy
CEO | Chief Executive Officer | 58 | 18-03-09 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 22-04-20 |
Timothy Scannell
BRD | Director/Board Member | 59 | 31-10-23 |
Daniel Levangie
BRD | Director/Board Member | 73 | 16-07-10 |
Director/Board Member | 69 | 24-04-09 | |
Paul Clancy
BRD | Director/Board Member | 62 | 18-03-21 |
Pierre Jacquet
BRD | Director/Board Member | 57 | 25-07-19 |
James Doyle
BRD | Director/Board Member | 78 | 24-07-14 |
Director/Board Member | 75 | 03-03-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 184 529 721 | 182 723 051 ( 99,02 %) | 0 | 99,02 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Medical Specialties
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-24,95% | 9,87 mld. | |
-11,29% | 2,74 mld. | |
-12,92% | 2,24 mld. | |
-16,74% | 1,63 mld. | |
+61,45% | 1,39 mld. | |
+24,25% | 772 mln. | |
-4,59% | 760 mln. | |
-21,94% | 516 mln. | |
-0,60% | 310 mln. | |
+6,47% | 219 mln. |
- Beurs
- Aandelen
- Koers EXAS
- Onderneming Exact Sciences Corporation